Effect of dabrafenib on melanoma cell lines harbouring the BRAF(V600D/R) mutations

BACKGROUND: Conventional therapeutic agents are largely unsatisfactory into the treatment of malignant melanoma. Recently, an innovative approach based on inhibitors of the mutated BRAF gene (which represents the most prevalent alteration in melanoma patients) appears very promising from the clinica...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Gentilcore, Giusy, Madonna, Gabriele, Mozzillo, Nicola, Ribas, Antoni, Cossu, Antonio, Palmieri, Giuseppe, Ascierto, Paolo A
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2013
Onderwerpen:
Correspondence
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3586362/
https://ncbi.nlm.nih.gov/pubmed/23317446
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-17
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items